Westend Advisors Stake in Biogen (BIIB) Increased by $1.05 Billion as Stock Declined; Affinity Investment Advisors Decreased Position in Ppl (PPL) by $541,912 as Market Value Rose

Biogen Inc. (NASDAQ:BIIB) Logo

Westend Advisors Llc increased its stake in Biogen Inc. (BIIB) by 3.33% based on its latest 2018Q4 regulatory filing with the SEC. Westend Advisors Llc bought 3,493 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 108,238 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $32.57 billion, up from 104,745 at the end of the previous reported quarter. Westend Advisors Llc who had been investing in Biogen Inc. for a number of months, seems to be bullish on the $63.06 billion market cap company. The stock increased 2.51% or $7.84 during the last trading session, reaching $320.56. About 1.11M shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since March 14, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 24/04/2018 – BIOGEN INC – QTRLY SPINRAZA REVENUE OF $364 MLN VS $47 MLN REPORTED LAST YEAR; 20/04/2018 – Biogen boosts investment in neurology with $1 bln Ionis deal; 01/05/2018 – Biogen Licensed Worldwide Rights to Aducanumab From Neurimmune in 2007; 29/05/2018 – Biogen at Bernstein Strategic Decisions CEO Conference Tomorrow; 05/04/2018 – Biogen, Samsung Bioepis to Make Royalty Payments to AbbVie; 24/04/2018 – BIOGEN INC – QTRLY TYSABRI REVENUE OF $$462 MLN VS. $545 MLN REPORTED LAST YEAR; 20/04/2018 – BIOGEN INC – IN COLLABORATION, IONIS WILL BE RESPONSIBLE FOR IDENTIFICATION OF ANTISENSE DRUG CANDIDATES BASED ON SELECTED TARGETS; 24/04/2018 – Biogen’s rain-making rare-disease drug hits a sales slump; 01/05/2018 – BIOGEN & NEURIMMUNE REPORT OPTION EXERCISE; 24/04/2018 – BIOGEN INC QTRLY NON-GAAP DILUTED EPS $6.05

Affinity Investment Advisors Llc decreased its stake in Ppl Corp (PPL) by 5.33% based on its latest 2018Q4 regulatory filing with the SEC. Affinity Investment Advisors Llc sold 19,354 shares as the company’s stock rose 4.89% with the market. The institutional investor held 343,865 shares of the central company at the end of 2018Q4, valued at $9.74 million, down from 363,219 at the end of the previous reported quarter. Affinity Investment Advisors Llc who had been investing in Ppl Corp for a number of months, seems to be less bullish one the $23.43B market cap company. The stock increased 0.09% or $0.03 during the last trading session, reaching $32.5. About 3.36 million shares traded. PPL Corporation (NYSE:PPL) has risen 14.62% since March 14, 2018 and is uptrending. It has outperformed by 10.25% the S&P500. Some Historical PPL News: 03/05/2018 – PPL CORP – QTRLY EARNINGS OF $0.65 PER SHARE AND EARNINGS FROM ONGOING OPERATIONS OF $0.74 PER SHARE; 03/05/2018 – PPL Corp 1Q Net $452M; 20/03/2018 – PPL CORP SAYS EXPECTS TO REITERATE ITS 2018 EARNINGS FORECAST RANGE OF $2.20 TO $2.40 PER SHARE – SEC FILING; 03/05/2018 – PPL Corp Sees 2018 EPS $2.11-EPS $2.31; 16/05/2018 – Scandinavian Investors Buy PPL, Southern; Sell Infosys: 13F; 08/05/2018 – PPL Corp Announces Public Offering of Common Stk With a Forward Component; 03/05/2018 – PPL Corp 1Q EPS 65c; 19/04/2018 – PPL Corporation to Conduct Webcast on First-Quarter 2018 Earnings Results; 12/04/2018 – 2017 Corporate Sustainability Report highlights PPL’s commitment to sustainability; 03/05/2018 – PPL CORP QTRLY OPERATING REVENUES $2,126 MLN VS $1,951 MLN

Westend Advisors Llc, which manages about $932.40 billion US Long portfolio, decreased its stake in Gilead Sciences Inc. (NASDAQ:GILD) by 74,155 shares to 445,807 shares, valued at $27.89B in 2018Q4, according to the filing. It also reduced its holding in Medtronic Inc. (NYSE:MDT) by 49,528 shares in the quarter, leaving it with 380,143 shares, and cut its stake in Disney Walt Co. (NYSE:DIS).

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.10, from 1.01 in 2018Q3. It fall, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. State Of Alaska Department Of Revenue has 31,186 shares. Churchill Mngmt Corporation accumulated 6,366 shares. 11,503 are held by Cibc Ww Inc. Cap Advsr Ltd has invested 0% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Kwmg Ltd Llc stated it has 7 shares or 0% of all its holdings. First Mercantile Trust owns 0.59% invested in Biogen Inc. (NASDAQ:BIIB) for 8,040 shares. Old National Bancorp In reported 0.22% in Biogen Inc. (NASDAQ:BIIB). Ferguson Wellman Cap Management Inc has 0.04% invested in Biogen Inc. (NASDAQ:BIIB) for 3,420 shares. Bremer Natl Association holds 0.28% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 4,231 shares. Carroll Assocs holds 0.02% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 531 shares. Cwm Ltd Llc reported 276 shares. Fincl Architects, New Jersey-based fund reported 108 shares. First State Bank Of Hutchinson holds 0.42% or 2,040 shares in its portfolio. Hotchkis & Wiley Cap Mgmt Ltd Liability has invested 0.32% in Biogen Inc. (NASDAQ:BIIB). Tirschwell And Loewy stated it has 65,333 shares.

Since September 26, 2018, it had 1 buy, and 1 insider sale for $20.22 million activity. Shares for $350,000 were sold by Ehlers Michael D on Wednesday, September 26.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Seekingalpha.com which released: “Biogen to buy Nightstar Therapeutics for $877M – Seeking Alpha” on March 04, 2019, also Finance.Yahoo.com with their article: “Biotech Companies Slump Midday With FDA Chief Set to Leave – Yahoo Finance” published on March 06, 2019, 247Wallst.com published: “Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses – 24/7 Wall St.” on February 22, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations – Nasdaq” published on March 04, 2019 as well as Nasdaq.com‘s news article titled: “Mid-Day Market Update: U.S. Stocks Turn Negative; Dow Down Over 350 Points – Nasdaq” with publication date: March 04, 2019.

Investors sentiment increased to 1.05 in Q4 2018. Its up 0.11, from 0.94 in 2018Q3. It increased, as 42 investors sold PPL shares while 207 reduced holdings. 68 funds opened positions while 194 raised stakes. 520.88 million shares or 0.84% less from 525.30 million shares in 2018Q3 were reported. State Street invested 0.09% in PPL Corporation (NYSE:PPL). First Republic Invest Mgmt has invested 0.01% in PPL Corporation (NYSE:PPL). Moreover, King Wealth has 0.09% invested in PPL Corporation (NYSE:PPL) for 8,378 shares. Murphy Capital Mngmt Incorporated has 0.04% invested in PPL Corporation (NYSE:PPL). Community Savings Bank Na has invested 0.06% of its portfolio in PPL Corporation (NYSE:PPL). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.04% in PPL Corporation (NYSE:PPL). Blackrock stated it has 0.09% in PPL Corporation (NYSE:PPL). Millennium Management Ltd Company reported 1.82 million shares. Proshare Advsrs Ltd Liability invested in 0.03% or 155,882 shares. 35,977 are owned by Public Sector Pension Board. 59,445 are held by Philadelphia Tru. Verity And Verity Ltd Limited Liability Company owns 7,625 shares for 0.06% of their portfolio. Eqis Management stated it has 14,604 shares or 0.03% of all its holdings. Epoch Inv Prtn stated it has 0.74% in PPL Corporation (NYSE:PPL). Argi Ser Ltd Liability Corporation owns 95,091 shares.

PPL Corporation (NYSE:PPL) Institutional Positions Chart